MoneyWorks4Me

Dr. Reddy’s Laboratories submits press release

28 Nov 2024 Evaluate

Dr. Reddy’s Laboratories has submitted a Press Release on “Dr. Reddy's launches Toripalimab in India, the first and only immuno-oncology drug approved for the treatment of nasopharyngeal carcinoma.”

The above information is a part of company’s filings submitted to BSE.


Peers
Company Name CMP
Sun Pharma. Inds. 1782.85
Dr. Reddys Labs. 1196.05
Cipla 1335.60
Lupin 2010.00
Zydus Lifesciences 1142.55
View more..